Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can shorter dialysis sessions still clean the blood effectively?

NCT ID NCT07348536

First seen Jan 19, 2026 · Last updated Jun 23, 2026 · Updated 23 times

Summary

This study tests whether shorter or standard-length dialysis sessions using expanded hemodialysis can remove waste products from the blood as well as a more intensive technique called high-volume hemodiafiltration. Fifteen adults with end-stage kidney disease will try three different session lengths (180, 210, and 240 minutes) and one session of the comparison method. Blood samples will measure how well each session removes toxins.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL DIALYSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran

    Mexico City, Mexico City, 14080, Mexico

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Expanded hemodialysis with medium cut-off membrane and high-volume online hemodiafiltration

What this could lead to

If successful, this study could help doctors personalize dialysis prescriptions by identifying the shortest effective treatment time for removing toxins.

What could go wrong

This is a very small, early-stage study with only 15 participants, so results may not apply to all dialysis patients. It measures toxin removal, not long-term health outcomes.

Conditions

The condition(s) this trial relates to.

Bronchiolitis Obliterans Syndrome chronic kidney disease uremia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.